MoneyWorks4Me

Venus Remedies - Quaterly Results

04 Feb 2025 Evaluate
The sales for the December 2024 quarter moved up 31.48% to Rs. 1725.40 millions as compared to Rs. 1312.30 millions during the corresponding quarter last year.Net Profit witnessed a 194.02% growth almost the double from Rs. 81.90 millions to Rs. 240.80  millions  of same quarter last year.Operating profit surged to 246.50 millions from the corresponding previous quarter of 154.20 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 1725.40 1312.30 31.48 4454.20 4000.50 11.34 5752.10 5376.60 6.98
Other Income 17.40 24.20 -28.10 140.10 74.10 89.07 113.20 101.70 11.31
PBIDT 246.50 154.20 59.86 614.70 470.10 30.76 722.00 717.00 0.70
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 345.60 154.20 124.12 713.80 470.10 51.84 722.00 717.00 0.70
Depreciation 52.00 63.00 -17.46 171.30 198.30 -13.62 255.50 313.70 -18.55
PBT 293.60 91.20 221.93 542.50 271.80 99.60 466.50 403.30 15.67
TAX 52.80 9.30 467.74 164.60 92.00 78.91 161.50 113.70 42.04
Deferred Tax -21.00 11.60 -281.03 28.20 23.60 19.49 39.30 113.70 -65.44
PAT 240.80 81.90 194.02 377.90 179.80 110.18 305.00 289.60 5.32
Equity 133.70 133.70 0.00 133.70 133.70 0.00 133.70 133.70 0.00
PBIDTM(%) 14.29 11.75 21.58 13.80 11.75 17.44 12.55 13.34 -5.88
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1145.25
Cipla 1359.75
Lupin 2047.20
Zydus Lifesciences 1105.00
View more..